Evidence map›Paper›PMID 27818384›Full record

ArticleBrain : a journal of neurology2017

Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy.

Cyril Laurent, Guillaume Dorothée, Stéphane Hunot, Elodie Martin, Yann Monnet, Marie Duchamp, Yuan Dong, François-Pierre Légeron, Antoine Leboucher, Sylvie Burnouf and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 184 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
184citing papers in PubMed, 1 pooled it
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

184 citing papers in PubMed, 1 synthesis or guideline pooled it, 280 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Immune signaling and function in neurodegeneration.The Journal of clinical investigation · 2026
    Review
  17. Article
  18. Article
  19. Article
  20. Immune dysfunction in Alzheimer disease.Nature reviews. Neuroscience · 2026
    Review

124 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 1 country.

Cyril Laurent1 Univ. Lille, Inserm, CHU-Lille, UMR-S 1172, Alzheimer and Tauopathies, Lille, France.
Guillaume Dorothée2 INSERM, UMRS 938, CdR Saint-Antoine, Laboratory Immune System, Neuroinflammation and Neurodegenerative Diseases, Hôpital St-Antoine, Paris, France.
Stéphane Hunot4 Inserm, U 1127, F-75013, Paris, France.
Elodie Martin4 Inserm, U 1127, F-75013, Paris, France.
Yann Monnet4 Inserm, U 1127, F-75013, Paris, France.
Marie Duchamp2 INSERM, UMRS 938, CdR Saint-Antoine, Laboratory Immune System, Neuroinflammation and Neurodegenerative Diseases, Hôpital St-Antoine, Paris, France.
Yuan Dong2 INSERM, UMRS 938, CdR Saint-Antoine, Laboratory Immune System, Neuroinflammation and Neurodegenerative Diseases, Hôpital St-Antoine, Paris, France.
François-Pierre Légeron4 Inserm, U 1127, F-75013, Paris, France.
Antoine Leboucher1 Univ. Lille, Inserm, CHU-Lille, UMR-S 1172, Alzheimer and Tauopathies, Lille, France.
Sylvie Burnouf1 Univ. Lille, Inserm, CHU-Lille, UMR-S 1172, Alzheimer and Tauopathies, Lille, France.
Emilie Faivre1 Univ. Lille, Inserm, CHU-Lille, UMR-S 1172, Alzheimer and Tauopathies, Lille, France.
Kévin Carvalho1 Univ. Lille, Inserm, CHU-Lille, UMR-S 1172, Alzheimer and Tauopathies, Lille, France.
Raphaëlle Caillierez1 Univ. Lille, Inserm, CHU-Lille, UMR-S 1172, Alzheimer and Tauopathies, Lille, France.
Nadège Zommer1 Univ. Lille, Inserm, CHU-Lille, UMR-S 1172, Alzheimer and Tauopathies, Lille, France.
Dominique Demeyer1 Univ. Lille, Inserm, CHU-Lille, UMR-S 1172, Alzheimer and Tauopathies, Lille, France.
Nathalie Jouy1 Univ. Lille, Inserm, CHU-Lille, UMR-S 1172, Alzheimer and Tauopathies, Lille, France.
Veronique Sazdovitch4 Inserm, U 1127, F-75013, Paris, France.
Susanna Schraen-Maschke1 Univ. Lille, Inserm, CHU-Lille, UMR-S 1172, Alzheimer and Tauopathies, Lille, France.
Cécile Delarasse4 Inserm, U 1127, F-75013, Paris, France.
Luc Buée1 Univ. Lille, Inserm, CHU-Lille, UMR-S 1172, Alzheimer and Tauopathies, Lille, France.
David Blum1 Univ. Lille, Inserm, CHU-Lille, UMR-S 1172, Alzheimer and Tauopathies, Lille, France david.blum@inserm.fr.
Inserm · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease is characterized by the combined presence of amyloid plaques and tau pathology, the latter being correlated with the progression of clinical symptoms. Neuroinflammatory changes are thought to be major contributors to Alzheimer's disease pathophysiology, even if their precise role still remains largely debated. Notably, to what extent immune responses contribute to cognitive impairments promoted by tau pathology remains poorly understood. To address this question, we took advantage of the THY-Tau22 mouse model that progressively develops hippocampal tau pathology paralleling cognitive deficits and reappraised the interrelationship between tau pathology and brain immune responses. In addition to conventional astroglial and microglial responses, we identified a CD8-positive T cell infiltration in the hippocampus of tau transgenic mice associated with an early chemokine response, notably involving CCL3. Interestingly, CD8-positive lymphocyte infiltration was also observed in the cortex of patients exhibiting frontemporal dementia with P301L tau mutation. To gain insights into the functional involvement of T cell infiltration in the pathophysiological development of tauopathy in THY-Tau22 mice, we chronically depleted T cells using anti-CD3 antibody. Such anti-CD3 treatment prevented hippocampal T cell infiltration in tau transgenic animals and reverted spatial memory deficits, in absence of tau pathology modulation. Altogether, these data support an instrumental role of hippocampal T cell infiltration in tau-driven pathophysiology and cognitive impairments in Alzheimer's disease and other tauopathies.

Indexed as

AgedAnimalsAntibodiesCD3 ComplexCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCerebral CortexChemokinesCognitive DysfunctionDisease Models, AnimalHippocampusHumansInflammationMiceMice, Inbred C57BLMice, TransgenicAntibodiesCD3 ComplexChemokineschemokinesfrontotemporal lobar degenerationneuroinflammationtauopathyT cells

Identifiers

PMID27818384
PMCPMC5382942
OpenAlexW2548767848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.